metoclopramide has been researched along with Acquired Metabolic Diseases, Brain in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The case of a patient with Parkinson's disease (PD) who experienced profound encephalopathy after short-term exposure to metoclopramide is described." | 1.38 | Encephalopathy associated with metoclopramide use in a patient with Parkinson's disease. ( Johnson, BR; Khan, MA; Messerschmidt, KA, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Messerschmidt, KA | 1 |
| Johnson, BR | 1 |
| Khan, MA | 1 |
1 other study available for metoclopramide and Acquired Metabolic Diseases, Brain
| Article | Year |
|---|---|
Encephalopathy associated with metoclopramide use in a patient with Parkinson's disease.
Topics: Aged; Brain Diseases, Metabolic; Humans; Male; Metoclopramide; Parkinson Disease | 2012 |